Atlas Trials

An Exploratory Clinical Study on Bortezomib for the Treatment of Refractory Rheumatoid Arthritis

Clinical trial NCT06215638 · UNKNOWN

Trial details

NCT number
NCT06215638
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2023-03-01
Primary completion
2024-06-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.